1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Revive Therapeutics Ltd (QB) (RVVTF)
  7. News

RVVTF

Revive Therapeutics (QB) News

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Revive Therapeutics Ltd (QB) RVVTF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00344 0.91% 0.38294 10:01:42
Open Price Low Price High Price Close Price Prev Close
0.385 0.378 0.39221 0.3795
more quote information »

Recent News

Date Time Source Heading
10/27/20219:15IHNWFeaturedKomo Plant Based Foods Plans to Launch Ghost Kitchen Concept through Komo Eats
10/26/20212:00IHNWFeaturedKWESST Announces New System to Counter Loitering Munition Drones
10/26/20212:00IHNWFeaturedLogiq's Advanced Consumer Scoring Technology Driving New Customer Program Offering Ramp-Up
9/22/202107:30IHNWRevive Therapeutics Included in AdvisorShares® Newly..
8/18/202106:00IHNWRevive Therapeutics Signs Exclusive Worldwide License..
8/12/202109:56IHNWRevive Confirms No Material Undisclosed Information
8/10/202108:52IHNWRevive Therapeutics Provides Update on Psychedelics Clinical..
7/15/202114:47IHNWRevive Therapeutics Provides Update on FDA Phase 3 Clinical..
7/15/202113:44SEEKRevive Therapeutics provides update on late-stage..
6/28/202108:00IHNWRevive Therapeutics Approved to Trade on the OTCQB Market
6/25/202115:56SEEKRevive Therapeutics gets approval to trade on OTCQB Market
6/17/202108:59IHNWRevive Collaborates With University of Health Sciences..
6/08/202109:12IHNWRevive Therapeutics Partners with Supriya to Pursue EUA for..
5/17/202109:48IHNWRevive Therapeutics Enters into Feasibility Agreement with..
5/17/202109:30SEEKRevive Therapeutics inks feasibility agreement with LTS..
5/03/202109:32IHNWRevive Therapeutics Enters Into Research Agreement with UCSF..
5/03/202109:27SEEKRevive inks research agreement to explore use of Bucillamine..
4/27/202109:51IHNWRevive Therapeutics Files For FDA Orphan Drug Designation..
4/27/202109:33SEEKRevive files for FDA orphan drug status for psilocybin in..
4/22/202108:26IHNWRevive Therapeutics Announces Successful Research Results..
3/24/202109:15IHNWRevive Therapeutics Provides Update on FDA Phase 3 Clinical..
3/24/202109:08SEEKRevive Therapeutics provides update on late-stage..
3/19/202107:56IHNWRevive Therapeutics Announces Successful Research Results..
3/19/202107:37SEEKRevive Therapeutics posts positive data from pre-clinical..
2/26/202109:01IHNWRevive Therapeutics Provides Update on FDA Phase 3 Clinical..
2/17/202109:53IHNWRevive Therapeutics Acquires Unique Psilocybin Assets
2/17/202109:38SEEKRevive Therapeutics acquires psilocybin assets for C$10M
2/11/202108:05IHNWRevive Therapeutics Provides Update on Cannabinoid..
1/27/202108:13IHNWRevive Therapeutics in Phase 3 clinical trial for COVID-19..
1/18/202109:51IHNWHow Combat Sports Are Researching Micro-Dosing Psychedelics..
1/14/202108:30IHNWRevive Therapeutics Announces Research Collaboration with..
12/31/202008:30IHNWDr. John Fahy Joins Revive Therapeutics as Scientific and..
12/23/202009:57IHNWRevive Therapeutics Provides Update on FDA Phase 3 Clinical..
12/22/202011:05IHNWRevive Therapeutics Announces LOI to Acquire PharmaTher's..
12/22/202008:20IHNWBiotech Report; Upcoming FDA Reviews and Promising Pipelines
12/03/202008:30IHNWEpidemiologist Dr. Joel Moody Joins Revive Therapeutics as..
11/12/202009:00IHNWRevive Therapeutics Provides Update on Oral Thin Film..
10/30/202013:39IHNWRevive Therapeutics Provides Update on FDA Phase 3 Clinical..
See more news about this stock »


Your Recent History
USOTC
RVVTF
Revive The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.